Thursday, 5 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Results Update

Aarti Drugs Results Update

Aarti Drugs reported FY26 revenue of ₹2,567.7 Crore, reflecting 7% year-on-year growth. Net profit reached ₹194.9 Crore, driven by strong sequential recovery and operational scale-up.

Key figures
Value₹2,568 Cr
Source

NSE filing, NSE: AARTIDRUGS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Aarti Drugs Ltd: key numbers

Share price
₹455.80
Market cap
₹4,160 Cr
Revenue (annual)
₹2,565 Cr
Net profit (annual)
₹194.9 Cr
P/E (TTM)
18.2×Sector 37.9×
Promoter holding
54.07%-0.36% QoQ
FII holding
2.26%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Aarti Drugs Ltd

All →
19:03 IST BSE
Financial Results

Aarti Drugs Q2 FY27 Results: Net Profit ₹82.8 Cr, Up 83.2% YoY

Aarti Drugs Ltd reported revenue from operations of ₹826.2 Cr (+26.6% YoY) and net profit of ₹82.8 Cr (+83.2% YoY) for Q2 FY27.

Key figure
Net profit ₹82.8 Cr · +83.2% YoY

Other results update announcements

All →